Found: 61
Select item for more details and to access through your institution.
Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00252-z
- By:
- Publication type:
- Article
IRF4 expression is low in Philadelphia negative myeloproliferative neoplasms and is associated with a worse prognosis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00249-8
- By:
- Publication type:
- Article
Recent advances and challenges of bispecific antibodies in solid tumors.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00250-1
- By:
- Publication type:
- Article
Elevated LDH greater than 400 U/L portends poorer overall survival in diffuse large B-cell lymphoma patients treated with CD19 CAR-T cell therapy in a real world multi-ethnic cohort.
- Published in:
- 2021
- By:
- Publication type:
- Letter
CD44 promotes hepatocellular carcinoma progression via upregulation of YAP.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00246-x
- By:
- Publication type:
- Article
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00245-y
- By:
- Publication type:
- Article
Involvement of classic and alternative non-homologous end joining pathways in hematologic malignancies: targeting strategies for treatment.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00242-1
- By:
- Publication type:
- Article
Red blood cells differentiated in vitro using sequential liquid and semi-solid culture as a pre-clinical model.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Roles of the intestinal microbiota and microbial metabolites in acute GVHD.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00240-3
- By:
- Publication type:
- Article
19-Hydroxybufalin inhibits non-small cell lung cancer cell proliferation and promotes cell apoptosis via the Wnt/β-catenin pathway.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00243-0
- By:
- Publication type:
- Article
Cell competition between wild-type and JAK2V617F mutant cells prevents disease relapse after stem cell transplantation in a murine model of myeloproliferative neoplasm.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Efficacy of combination of venetoclax with azacitidine or chemotherapy in refractory/relapse acute leukemias of ambiguous lineage, not otherwise specified.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndrome.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00238-x
- By:
- Publication type:
- Article
Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00236-z
- By:
- Publication type:
- Article
COVID-19 vaccination associated severe immune thrombocytopenia.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00235-0
- By:
- Publication type:
- Article
Progress in molecular feature of smoldering mantle cell lymphoma.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00232-3
- By:
- Publication type:
- Article
Function and clinical significance of N6-methyladenosine in digestive system tumours.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00234-1
- By:
- Publication type:
- Article
Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00233-2
- By:
- Publication type:
- Article
Whole exome sequencing reveals a novel LRBA mutation and clonal hematopoiesis in a common variable immunodeficiency patient presented with hemophagocytic lymphohistiocytosis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Recent advances in Lynch syndrome.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00231-4
- By:
- Publication type:
- Article
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00230-5
- By:
- Publication type:
- Article
YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00227-0
- By:
- Publication type:
- Article
Platelet-driven coagulopathy in COVID-19 patients: in comparison to seasonal influenza cases.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00228-z
- By:
- Publication type:
- Article
Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00224-3
- By:
- Publication type:
- Article
Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Pan-cancer analysis reveals tumor-associated macrophage communication in the tumor microenvironment.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00226-1
- By:
- Publication type:
- Article
The metabolic adaptation mechanism of metastatic organotropism.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00223-4
- By:
- Publication type:
- Article
Histological verification of the treatment effect of tirabrutinib for relapsed/refractory primary central nervous system lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00221-6
- By:
- Publication type:
- Article
Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00207-4
- By:
- Publication type:
- Article
Exosomes from BM-MSCs promote acute myeloid leukemia cell proliferation, invasion and chemoresistance via upregulation of S100A4.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00220-7
- By:
- Publication type:
- Article
Evaluation of acute myeloid leukemia blast percentage on MethylC-Capture Sequencing results.
- Published in:
- 2021
- By:
- Publication type:
- Letter
PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00218-1
- By:
- Publication type:
- Article
VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Correction to: Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00215-4
- By:
- Publication type:
- Article
Platelet desialylation and TFH cells–the novel pathway of immune thrombocytopenia.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00214-5
- By:
- Publication type:
- Article
Targeting phosphoinositide 3-kinases and histone deacetylases in multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00213-6
- By:
- Publication type:
- Article
Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00211-8
- By:
- Publication type:
- Article
SEPHS1 promotes SMAD2/3/4 expression and hepatocellular carcinoma cells invasion.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00212-7
- By:
- Publication type:
- Article
Etanercept as a new therapeutic option for cytokine release syndrome following chimeric antigen receptor T cell therapy.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphoma.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00203-8
- By:
- Publication type:
- Article
Circulating RNA biomarkers in diffuse large B-cell lymphoma: a systematic review.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00208-3
- By:
- Publication type:
- Article
Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial.
- Published in:
- 2021
- By:
- Publication type:
- Letter
MiRNA-mediated EMT and CSCs in cancer chemoresistance.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00206-5
- By:
- Publication type:
- Article